FDA grants orphan drug designation to Algernon's ifenprodil, while exclusivity remains unclear
As the FDA remains silent on orphan drug exclusivity in the wake of a controversial court case, the agency continues to hand out new designations …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
